JP2021518150A5 - - Google Patents
Info
- Publication number
- JP2021518150A5 JP2021518150A5 JP2020551263A JP2020551263A JP2021518150A5 JP 2021518150 A5 JP2021518150 A5 JP 2021518150A5 JP 2020551263 A JP2020551263 A JP 2020551263A JP 2020551263 A JP2020551263 A JP 2020551263A JP 2021518150 A5 JP2021518150 A5 JP 2021518150A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- rna
- sequence
- replication
- closed circular
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024110895A JP2024138410A (ja) | 2018-03-21 | 2024-07-10 | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862645892P | 2018-03-21 | 2018-03-21 | |
| US62/645,892 | 2018-03-21 | ||
| PCT/US2019/023209 WO2019183248A1 (en) | 2018-03-21 | 2019-03-20 | Viral and non-viral nanoplasmid vectors with improved production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024110895A Division JP2024138410A (ja) | 2018-03-21 | 2024-07-10 | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021518150A JP2021518150A (ja) | 2021-08-02 |
| JPWO2019183248A5 JPWO2019183248A5 (https=) | 2022-03-29 |
| JP2021518150A5 true JP2021518150A5 (https=) | 2022-03-29 |
| JP7520719B2 JP7520719B2 (ja) | 2024-07-23 |
Family
ID=66001381
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551263A Active JP7520719B2 (ja) | 2018-03-21 | 2019-03-20 | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター |
| JP2024110895A Pending JP2024138410A (ja) | 2018-03-21 | 2024-07-10 | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024110895A Pending JP2024138410A (ja) | 2018-03-21 | 2024-07-10 | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12600984B2 (https=) |
| EP (2) | EP3768846B1 (https=) |
| JP (2) | JP7520719B2 (https=) |
| KR (1) | KR20210016330A (https=) |
| CN (2) | CN112154208B (https=) |
| AU (2) | AU2019240068B2 (https=) |
| CA (1) | CA3093346A1 (https=) |
| DK (1) | DK3768846T5 (https=) |
| ES (1) | ES2950736T3 (https=) |
| FI (1) | FI3768846T3 (https=) |
| LT (1) | LT3768846T (https=) |
| SG (1) | SG11202009009UA (https=) |
| WO (1) | WO2019183248A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019183248A1 (en) * | 2018-03-21 | 2019-09-26 | Nature Technology Corporation | Viral and non-viral nanoplasmid vectors with improved production |
| US20220042038A1 (en) * | 2018-12-20 | 2022-02-10 | Poseida Therapeutics, Inc. | Nanotransposon compositions and methods of use |
| GB2700048B (en) | 2019-09-18 | 2026-03-04 | Aldevron Llc | synthetic dna vectors and method of use |
| JP7833134B2 (ja) * | 2020-03-11 | 2026-03-19 | アルデブロン，エル．エル．シー． | 細菌宿主株 |
| CA3201499A1 (en) | 2020-11-13 | 2022-05-19 | Catamaran Bio, Inc. | Genetically modified natural killer cells and methods of use thereof |
| CA3223292A1 (en) | 2021-06-25 | 2022-12-29 | Laura Van Lieshout | Adeno-associated virus packaging systems |
| US20250114452A1 (en) | 2021-08-04 | 2025-04-10 | The Regents Of The University Of Colorado, A Body Corporate | Lat activating chimeric antigen receptor t cells and methods of use thereof |
| CN114045305B (zh) * | 2021-10-15 | 2023-03-24 | 深圳市深研生物科技有限公司 | 多转座子系统 |
| WO2023114901A2 (en) | 2021-12-15 | 2023-06-22 | Oxford Biomedica Solutions Llc | Methods and compositions for the production of adeno-associated virus |
| WO2023172514A1 (en) | 2022-03-07 | 2023-09-14 | Catamaran Bio, Inc. | Engineered immune cell therapeutics targeted to her2 and methods of use thereof |
| US20250354159A1 (en) * | 2022-06-13 | 2025-11-20 | Nanjing GenScript Biotech Co., Ltd. | Wild-type-mutant pi protein switching expression system capable of increasing efficiency of preparing screening-tag-free plasmid |
| JP2025525583A (ja) | 2022-07-19 | 2025-08-05 | ランパート バイオサイエンス インコーポレイテッド | 非免疫原性環状非ウイルス性ｄｎａベクター |
| CN117305339B (zh) * | 2023-11-30 | 2024-02-06 | 苏州左旋星生物科技有限公司 | 优化大肠杆菌基因编辑的载体及其应用 |
| WO2025160245A1 (en) | 2024-01-25 | 2025-07-31 | Aldevron, L.L.C. | Viral and non-viral nanoplasmid vectors with improved production |
| WO2025231315A2 (en) | 2024-05-03 | 2025-11-06 | Aldevron, L.L.C. | Bacterial host strains |
| WO2026076187A1 (en) * | 2024-10-03 | 2026-04-09 | Aldevron, L.L.C. | Compositions and methods for microbial production of antibiotic-free closed-ended linear dna |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04197185A (ja) * | 1990-11-28 | 1992-07-16 | Mitsui Toatsu Chem Inc | 酵母発現ベクター及びこれを用いた誘導的発現 |
| GB9506051D0 (en) * | 1995-03-24 | 1995-05-10 | Univ Singapore | Gene expression |
| FR2738842B1 (fr) | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
| US7279313B2 (en) | 1995-09-15 | 2007-10-09 | Centelion | Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| US5922583A (en) | 1995-10-17 | 1999-07-13 | Biostar Inc. | Methods for production of recombinant plasmids |
| US6709844B1 (en) * | 2000-11-16 | 2004-03-23 | Mannkind Corporation | Avoidance of undesirable replication intermediates in plasmid propagation |
| JP2004267001A (ja) * | 2000-08-16 | 2004-09-30 | Kansai Tlo Kk | トランスジェニック哺乳動物及びその作製方法並びにこれを用いた遺伝子機能の解明方法 |
| UY26317A1 (es) * | 2000-08-30 | 2000-10-31 | Alfonso Cayota Carlos Pritsch | Sistema de produccion de trombopoyetina humana por celulas de mamiferos en cultivo |
| FR2821855B1 (fr) | 2001-03-09 | 2004-04-02 | Cayla | Genes synthetiques et plasmides bacteriens depourvus de cpg |
| CA2794446C (en) * | 2001-04-04 | 2015-09-08 | Genencor International, Inc. | Uncoupled productive and catabolic host cell pathways |
| US20060088837A1 (en) * | 2002-04-26 | 2006-04-27 | Kazunari Taira | Expression system for stem-loop rna molecule having rnai effect |
| WO2005003359A1 (ja) * | 2003-07-08 | 2005-01-13 | Japan Science And Technology Corporation | トランスジェニック生物を作製する方法およびシステム |
| GB0327056D0 (en) | 2003-11-20 | 2003-12-24 | Cobra Biolog Ltd | Plasmid maintenance |
| MX2007001889A (es) | 2004-08-19 | 2007-05-09 | Nature Technology Corp | Proceso para la fermentacion de adn de plasmido. |
| CA2577519A1 (en) * | 2004-08-23 | 2006-03-30 | Nucleonics, Inc. | Multiple rna polymerase iii promoter expression constructs |
| TWI311152B (en) | 2004-09-17 | 2009-06-21 | Boehringer Ingelheim Rcv Gmbh & Co K | Host-vector system for antibiotic-free cole1 plasmid propagation |
| US9018012B2 (en) | 2005-01-20 | 2015-04-28 | Nature Technology Corporation | Vectors and methods for genetic immunization |
| EP1921140B1 (en) | 2005-07-05 | 2011-12-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Mutant transposon vector and use thereof |
| US9017966B2 (en) | 2007-05-23 | 2015-04-28 | Nature Technology Corporation | E. coli plasmid DNA production |
| EP2152889B1 (en) * | 2007-05-29 | 2017-03-15 | Nature Technology Corporation | Vectors and methods for genetic immunization |
| ES2651911T3 (es) * | 2007-08-14 | 2018-01-30 | Commonwealth Scientific And Industrial Research Organisation | Métodos mejorados de silenciamiento génico |
| US9045759B2 (en) | 2009-01-21 | 2015-06-02 | James Arthur Williams | DNA plasmids with improved copy number |
| US9012226B2 (en) | 2009-03-13 | 2015-04-21 | Nature Technology Corporation | Bacterial strains with improved plasmid stability |
| US9506082B2 (en) | 2010-04-12 | 2016-11-29 | Nature Technology Corporation | Eukaryotic expression vectors resistant to transgene silencing |
| EP2788483B1 (en) * | 2011-12-07 | 2018-06-27 | Glenmark Pharmaceuticals S.A. | Expression cassette |
| US9550998B2 (en) * | 2012-08-29 | 2017-01-24 | Nature Technology Corporation | DNA plasmids with improved expression |
| US20150322439A1 (en) * | 2012-11-19 | 2015-11-12 | Nature Technology Corporation | Replicative minicircle vectors with improved expression |
| CA2914604A1 (en) * | 2013-06-06 | 2014-12-11 | Novartis Ag | Influenza virus reassortment |
| WO2017025447A1 (en) | 2015-08-10 | 2017-02-16 | Curevac Ag | Method of increasing the replication of a circular dna molecule |
| US11230720B2 (en) | 2015-10-14 | 2022-01-25 | Audentes Therapeutics, Inc. | Nucleic acid molecules containing spacers and methods of use thereof |
| WO2019183248A1 (en) | 2018-03-21 | 2019-09-26 | Nature Technology Corporation | Viral and non-viral nanoplasmid vectors with improved production |
| US20220042038A1 (en) * | 2018-12-20 | 2022-02-10 | Poseida Therapeutics, Inc. | Nanotransposon compositions and methods of use |
-
2019
- 2019-03-20 WO PCT/US2019/023209 patent/WO2019183248A1/en not_active Ceased
- 2019-03-20 EP EP19715345.5A patent/EP3768846B1/en active Active
- 2019-03-20 AU AU2019240068A patent/AU2019240068B2/en active Active
- 2019-03-20 SG SG11202009009UA patent/SG11202009009UA/en unknown
- 2019-03-20 DK DK19715345.5T patent/DK3768846T5/da active
- 2019-03-20 KR KR1020207030139A patent/KR20210016330A/ko not_active Ceased
- 2019-03-20 JP JP2020551263A patent/JP7520719B2/ja active Active
- 2019-03-20 FI FIEP19715345.5T patent/FI3768846T3/fi active
- 2019-03-20 LT LTEPPCT/US2019/023209T patent/LT3768846T/lt unknown
- 2019-03-20 CN CN201980034026.9A patent/CN112154208B/zh active Active
- 2019-03-20 EP EP22194460.6A patent/EP4151735A1/en active Pending
- 2019-03-20 CA CA3093346A patent/CA3093346A1/en active Pending
- 2019-03-20 CN CN202510450562.4A patent/CN120249340A/zh active Pending
- 2019-03-20 ES ES19715345T patent/ES2950736T3/es active Active
-
2020
- 2020-09-18 US US17/026,101 patent/US12600984B2/en active Active
-
2024
- 2024-07-10 JP JP2024110895A patent/JP2024138410A/ja active Pending
-
2025
- 2025-05-08 AU AU2025203312A patent/AU2025203312A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021518150A5 (https=) | ||
| CN112513250A (zh) | 用于跟踪和操纵细胞rna的融合蛋白和融合核糖核酸 | |
| JP2023503455A (ja) | アデノ随伴ウイルスベクター変種 | |
| JPWO2019183248A5 (https=) | ||
| CN1384759A (zh) | 单链寡聚脱氧核苷酸突变载体 | |
| JP2005517447A (ja) | Ｔｎ５結合Ｃｒｅ／ｌｏｘＰ切除システムによる最小化ゲノムを含む新規菌株の構築 | |
| CN103834686B (zh) | 高效克隆筛选表达载体、其制备方法及用途 | |
| EP4650453A1 (en) | Antibiotic-free miniplasmid, and preparation method therefor and use thereof | |
| US20250019667A1 (en) | Adenoviral helper plasmid | |
| WO2021189110A1 (en) | Dna altering proteins and uses therefor | |
| JPWO2021183827A5 (https=) | ||
| WO2024137767A1 (en) | Compositions and methods for modifying dux4 | |
| CN1187452C (zh) | 启动子 | |
| WO2024040202A1 (en) | Fusion proteins and uses thereof for precision editing | |
| WO2023147558A2 (en) | Crispr methods for correcting bag3 gene mutations in vivo | |
| Kawai et al. | Correction of substitution, deletion, and insertion mutations by 5′-tailed duplexes | |
| CN115044583A (zh) | 用于基因编辑的rna框架和基因编辑方法 | |
| WO2023060589A1 (zh) | 多转座子系统 | |
| JPWO2020204055A5 (https=) | ||
| US20250135032A1 (en) | Crispr methods for correcting bag3 gene mutations in vivo | |
| US20230279398A1 (en) | Treating human t-cell leukemia virus by gene editing | |
| WO2025024285A1 (en) | Compositions for the modification of the human c9orf72 gene | |
| WO2025261252A1 (zh) | 一种高效碱基编辑系统及其制法与应用 | |
| WO2024263707A1 (en) | Compositions for the treatment of amyotrophic lateral sclerosis | |
| WO2025072763A2 (en) | Compositions and methods for precision editing with cas dimers |